Projects per year
Organization profile
This doctoral research program was established in collaboration with Academia Sinica to cultivate interdisciplinary research that focuses on tumor-related medicine. Academia Sinica is Taiwan’s leading research institute and has outstanding scientific researchers and cutting-edge equipment for advanced research. TMU also works in collaboration with its three affiliated hospitals and has access to their clinical resources.
Through these relationships, the Cancer Biology and Drug Discovery program offers students a great opportunity to build a career with excellent research support. We enroll top students from around the world, and provide a strong curriculum of interdisciplinary training as well as a learning environment where students work with many research specialists.
From basic research to translational medicine, we develop cutting-edge therapeutic strategies for cancer prevention and treatment. We work hard for cancer patients, seeking to extend their lives and improve their quality of life.
Fingerprint
Dive into the research topics where Ph.D. Program for Cancer Molecular Biology and Drug Discovery is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Chi-Long Chen
- Department of Pathology - Professor
- Graduate Institute of Clinical Medicine - Joint-Appointment Professor
- International Master/Ph.D. Program in Medicine - Joint-Appointment Professor
- Professional Master Program in Artificial Intelligence in Medicine - Joint-Appointment Professor
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery - Joint-Appointment Professor
- Taipei Medical University Hospital - Visiting Staff
- TMU Research Center of Cancer Translational Medicine - Member
- TMU Research Center of Artificial Intelligence in Medicine and Health - Member
Person: Researcher
-
Hsin-Yi Chen
- Master Program in Graduate Institute of Cancer Biology and Drug Discovery - Associate Professor
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery - Joint-Appointment Associate Professor
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
-
Ruei-Ming Chen
- Graduate Institute of Medical Sciences - Professor
- International Master/Ph.D. Program in Medicine - Joint-Appointment Professor
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery - Joint-Appointment Professor
- TMU Research Center of Cancer Translational Medicine - Member
- TMU Research Center of Neuroscience - Member
Person: Researcher
-
分析口腔癌前病灶非編碼核糖核酸之變化以發展口腔癌和潛在惡性疾病的早期診斷測試
3/1/22 → 2/28/23
Project: C - Project of Alliance › o - Chi Mei Medical Center
-
探討長鏈非編碼RNA-CRNDE在代謝性疾病中的角色
3/1/22 → 2/28/23
Project: C - Project of Alliance › o - Chi Mei Medical Center
-
胰臟癌特異性miRNA 與 MIR31HG的關聯性研究與開發ncRNA的療法
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
Research output
-
A chemical probe inhibitor targeting STAT1 restricts cancer stem cell traits and angiogenesis in colorectal cancer
Chou, P. H., Luo, C. K., Wali, N., Lin, W. Y., Ng, S. K., Wang, C. H., Zhao, M., Lin, S. W., Yang, P. M., Liu, P. J., Shie, J. J. & Wei, T. T., Dec 2022, In: Journal of Biomedical Science. 29, 1, 20.Research output: Contribution to journal › Article › peer-review
Open Access -
A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic Lesions
Hsu, F. C., Lee, H. L., Chen, Y. J., Shen, Y. A., Tsai, Y. C., Wu, M. H., Kuo, C. C., Lu, L. S., Yeh, S. D., Huang, W. S., Shen, C. N. & Chiou, J. F., Jan 1 2022, In: Cancers. 14, 2, 445.Research output: Contribution to journal › Article › peer-review
Open Access -
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
Wang, W. L., Batzorig, U., Hung, C. S., Wei, P. L., Huang, C. Y. & Chang, Y. J., 2022, In: BioMed Research International. 2022, 1322788.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Datasets
-
Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach
Chao, M. (Contributor), Lin, T. E. (Contributor), HuangFu, W. (Contributor), Chang, C. (Contributor), Tu, H. (Contributor), Chen, L. (Contributor), Yen, S. (Contributor), Sung, T. (Contributor), Huang, W. (Contributor), Yang, C. (Contributor), Pan, S. (Contributor) & Hsu, K. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.13213424.v1, https://tandf.figshare.com/articles/dataset/Identification_of_a_dual_TAOK1_and_MAP4K5_inhibitor_using_a_structure-based_virtual_screening_approach/13213424/1
Dataset
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T. (Contributor), Hsieh, Y. (Contributor), Chou, C. (Contributor) & Yang, P. (Contributor), Unknown Publisher, Jan 1 2018
DOI: 10.6084/m9.figshare.7346312.v1, https://rs.figshare.com/articles/journal_contribution/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7346312/1
Dataset
-
EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Lee, Y. (Contributor), Huang, H. (Contributor), Chang, F. (Contributor), Wei, P. (Contributor), HuangFu, W. (Contributor), Sung, T. (Contributor), Pan, S. (Contributor), Cheng, C. (Contributor), Cheng, Y. (Contributor) & Huang, C. (Contributor), figshare Academic Research System, Jan 1 2021
DOI: 10.6084/m9.figshare.c.5341486.v1, https://doi.org/10.6084%2Fm9.figshare.c.5341486.v1
Dataset